Kate Bingham, SV Managing Partner joined Professor Sir Simon Wessely, Royal Society of Medicine immediate Past-President, for a conversation about her career, the strategy and strive behind the UK’s historical COVID-19 vaccine effort, and how the pandemic has changed the biotech and pharmaceutical sector and public opinion.
PROUD SIGNATORIES
We invest in talented innovators. We strongly adhere to the view that diversity, including under-represented groups, strongly adds to success. If you are an entrepreneur seeking investment and a partner who can help you to build your business, we would love to hear from you. Please get in contact with our team.